United States
Medical University of South Carolina, South Carolina Clinical & Translational Research Institute
MUSC graduate students and postdoctoral fellows are earning digital badges in science communications that document their skills and help to prepare them for future careers.
Medical University of South Carolina scientists have uncovered a link between the innate immune system and cognitive problems after repeated concussions. Their study, published in Signal Transduction and Targeted Therapy, shows that repeated concussions activate the complement system in ways that can worsen brain damage.
MUSC’s SCTR Institute will host a scientific retreat on March 6, 2026, on the subject of cellular and gene therapy.
A research team led by a researcher at the Medical University of South Carolina and partnering institutions has been awarded $1 million from Breakthrough T1D, the leading global type 1 diabetes research and advocacy organization, to develop a revolutionary therapy for type 1 diabetes.
Hollings Cancer Center researchers have been awarded a federal grant to help people with HIV to quit smoking by changing practices in Ryan White clinics.
A set of three new tools out of the Medical University of South Carolina, introduced in recent articles in the Journal of Clinical and Translational Science, seeks to improve the rigor of decentralized clinical trials. CheatBlocker helps to address enrollment fraud; QuotaConfig aims to counter bias in clinical trials and MyTrials facilitates remote biomarker data collection throughout the trial.
Could the way we preserve donor milk shape preemie gut health? A new MUSC study connects the dots between storage practices and GI outcomes.
Adults with the dual diagnosis of Down syndrome and congenital heart defects show no reduction in community engagement, employment and quality of life, despite facing considerably more medical challenges than people with Down syndrome alone, reports a Medical University of South Carolina research team in Pediatric Cardiology.
MUSC study finds a link between inflammation and poor neonatal and pregnancy outcomes.
Transplanted organs are more likely to be rejected by the immune system when there is a mismatch between donor and recipient human leukocyte antigens (HLA). A MedicResearchers at the Medical University of South Carolina have engineered a new type of genetically modified immune cell that could help organ transplant patients who are prone to rejection.